| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/25/2001 | EP1093516A2 Mammalian genes; dendritic cell prostaglandin-like transporter (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
| 04/25/2001 | EP1093465A2 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 04/25/2001 | EP1093464A2 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 04/25/2001 | EP1093462A1 Compound capable of inhibiting the binding of a protein to mast cells, use of the compound for the preparation of a drug, a pharmaceutical composition, a method of diagnosing a disease, and a method of selection |
| 04/25/2001 | EP1093461A1 Microsporidium polar tube proteins, nucleic acids coding for said proteins and their uses |
| 04/25/2001 | EP1093460A1 Dolastatin 15 derivatives |
| 04/25/2001 | EP1093457A1 Cytokine receptor common gamma chain like |
| 04/25/2001 | EP1093383A1 Drug delivery system comprising a homeobox peptide |
| 04/25/2001 | EP1093381A1 Antigenic peptides derived from telomerase |
| 04/25/2001 | EP1093380A2 Component b as angiogenic agent in combination with human growth factors |
| 04/25/2001 | EP1093379A2 Use of inhibitors of protein kinase c epsilon to treat pain |
| 04/25/2001 | EP1093378A1 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots |
| 04/25/2001 | EP1093372A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
| 04/25/2001 | EP1093359A1 Method for preparing fibrillin from cnidaria, and resulting compositions useful in cosmetics |
| 04/25/2001 | EP1007068A4 Process for preparing synthetic soil-extract materials and medicaments based thereon |
| 04/25/2001 | EP0701568B1 New peptide derivatives |
| 04/25/2001 | CN1292820A i (Neisseria meningitidis) antigens |
| 04/25/2001 | CN1292798A Methods and compositions for treating and diagnosing insulin related disorders |
| 04/25/2001 | CN1292712A Reverse phase connective tissue repair composition |
| 04/25/2001 | CN1292705A Protein-free preparations |
| 04/25/2001 | CN1292700A IgE antibody production inhibitors and autoimmune diseases inhibitors |
| 04/25/2001 | CN1292689A Fat emulsions for inhalational administration |
| 04/25/2001 | CN1292684A Emulsion preconcentrate containing cyclosporin or macrolide |
| 04/25/2001 | CN1292420A New human NADH oxido-reductase composite I subunit and its code sequence |
| 04/25/2001 | CN1292419A New human III type ethanol dehydrogenase and its code sequence |
| 04/25/2001 | CN1292386A New polypeptide-HRMT 35 and polynucleotide coding this polypeptide |
| 04/25/2001 | CN1292383A New polypeptide-human glutamine enrichment factor 56 and polynucleotide coding this polypeptide |
| 04/25/2001 | CN1292382A New polypeptide-ID-17 and polynucleotide coding this polypeptide |
| 04/25/2001 | CN1064970C Non-densatured extraction method of medical collagen protein |
| 04/24/2001 | US6222027 Molecules expressed in hippocampus |
| 04/24/2001 | US6222026 Gcp |
| 04/24/2001 | US6222024 Nucleic acids encoding a human immunodeficiency virus type 1 (HIV-1) integrase interactor protein (INI-1) |
| 04/24/2001 | US6222022 Amino acid sequences of protein related to glial-derived neurotrophic factor and neurturin; diagnosis and treatment of alzheimer's/parkinson's/huntington's diseases, strokes, brain and spinal chord injuries, amyotrophic lateral sclerosis |
| 04/24/2001 | US6222021 Amino acid sequence of protein from horseshoe crab; for removing endotoxins from solutions; biosensors |
| 04/24/2001 | US6222020 Immunogens of at least five consecutive amino acids of a tandem repeat sequence linked to immunogenic carrier; antibodies; diagnosis; anticarcinogenic agents |
| 04/24/2001 | US6222019 Binds to human interleukin-1 receptor associated kinase-2; diagnosis/therapy of sarcoidosis, tuberculosis, onchocerciasis, allergies, arteriosclerosis, autoimmune disorders; anticancer/antiinflammatory/antiarthritic agents |
| 04/24/2001 | US6222018 Antibody which binds to transcription factor; for detection in samples; for screening expression libraries |
| 04/24/2001 | US6222015 Amino acid sequence; for screening ligands; treatment and prevention of abnormal bone resorption, cardiovascular diseases, cancer, or central nervous system disorders; anticarcinogenic agents |
| 04/24/2001 | US6222014 Amino acid sequence of protein from ribonucleotide diphosphate reductase family; drug screening of bactericides and antibiotics |
| 04/24/2001 | US6222012 Isolated nonapeptides presented by HLA molecules, and uses thereof |
| 04/24/2001 | US6222010 Amino acid sequence of nonapeptide; diagnosis; anticarcinogenic agents; antigens; antibodies |
| 04/24/2001 | US6221958 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 04/24/2001 | US6221911 Reducing subcutaneous fat deposits in a subject; improving the skin condition of a subject |
| 04/24/2001 | US6221897 Hypolipidemics. |
| 04/24/2001 | US6221893 Administration of histamine for therapeutic purposes |
| 04/24/2001 | US6221888 Antihistamine, antiinflammatory agent, autoimmune disease, rheumatic disorders |
| 04/24/2001 | US6221881 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 04/24/2001 | US6221854 Method of promoting bone growth with hyaluronic acid and growth factors |
| 04/24/2001 | US6221849 Inhibiting tumor growth |
| 04/24/2001 | US6221848 In vivo administration to the subject of a polynucleotide encoding a protein that is transiently expressed in said subject; preventing esophagitis during treatment of lung cancer patients with ionizing radiation and/or chemotherapy |
| 04/24/2001 | US6221847 Administering a bacteriocin produced by dairy propionibacteria |
| 04/24/2001 | US6221846 Ophthalmic drug compositions |
| 04/24/2001 | US6221845 Use of these substances for the manufacture of a pharmaceutical composition useful against symptoms caused by micro-organisms releasing kinins. |
| 04/24/2001 | US6221844 Texenomycins having a specific amino acid sequence |
| 04/24/2001 | US6221842 Method of treating muscular disorders |
| 04/24/2001 | US6221841 Molecules show a modular structure comprising a domain homologous to the yeast sec7 gene product and a pleckstrin homology (ph) domain. |
| 04/24/2001 | US6221840 Intestinal trefoil proteins |
| 04/24/2001 | US6221839 FIt4 ligand and methods of use |
| 04/24/2001 | US6221838 Administering an analog of an obesity protein. |
| 04/24/2001 | US6221837 Form complexes with zinc++, comprising an insulin hexamer and approximately 5 to 9 mol of zinc++ per hexamer. |
| 04/24/2001 | US6221676 DNA encoding human leukotriene C4 synthase, polypeptides and uses therefor |
| 04/24/2001 | US6221675 TNF receptors, TNF binding proteins and DNAs coding for them |
| 04/24/2001 | US6221659 Blood coagulation protein antagonists and uses therefor |
| 04/24/2001 | US6221633 Insulin derivatives having a rapid onset of action |
| 04/24/2001 | US6221631 tktA |
| 04/24/2001 | US6221628 Nucleotide sequences coding preferential polypeptide for use in diagnosis and treatment atherosclerosis, ischemia, hypertension, restenosis and arterial inflammation |
| 04/24/2001 | US6221627 cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor |
| 04/24/2001 | US6221615 Detection of modulators cell killing; mixing modulators of heterodimerization and detecting reduction in heterodimer forming activity |
| 04/24/2001 | US6221609 Isolate nucleic acid encoding human MGLUR8 |
| 04/24/2001 | US6221591 Determination of a genetic risk factor for infection and other diseases, and detection of activated phagocytes |
| 04/24/2001 | US6221580 Anti-idiotypic and its uses in diagnosis and therapy in HIV-related disease |
| 04/24/2001 | US6221577 Peptides which induce immune response and are useful in the diagnosis of urogenital tumors |
| 04/24/2001 | US6221425 Lubricious hydrophilic coating for an intracorporeal medical device |
| 04/24/2001 | US6221404 Oral administration of the bacillus cereus cip 5832 probiotic and lysozyme or one of its salts to the animal |
| 04/24/2001 | US6221400 Methods of treating mammals using nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors |
| 04/24/2001 | US6221378 Mixed micellar delivery system and method of preparation |
| 04/24/2001 | US6221376 Glial cell line-derived neurotrophic factor |
| 04/24/2001 | US6221367 Exposing a biologically active agent to a complexing perturbant to reversibly transform the biologically active agent to the intermediate state and to form a transportable supramolecular complex |
| 04/24/2001 | US6221366 Intestinal protozoal vaccines |
| 04/24/2001 | US6221355 Anti-pathogen system and methods of use thereof |
| 04/24/2001 | US6221354 Feeding an antigen to a mammal, wherein the mammal is not allowed to ingest a fat-soluble component |
| 04/24/2001 | US6221353 The use of these proteins in vaccines or for the detection of tuberculosis. |
| 04/24/2001 | US6221351 The enhancement of antitumor immunity and in the treatment of cancer in a tumor-bearing host. |
| 04/24/2001 | US6221349 Adeno-associated vectors for expression of factor VIII by target cells |
| 04/24/2001 | US6221348 Immune lymphokine-mediated control of Salmonellosis in swine |
| 04/24/2001 | CA2220055C Dipeptides which promote release of growth hormone |
| 04/24/2001 | CA2176620C Hepatic growth factor receptor is the met proto-oncogene |
| 04/24/2001 | CA2135277C Anti-receptor agents to the vitamin b12/transcobalamin ii receptor |
| 04/24/2001 | CA2079172C Cyclohexapeptidyl hydroxypropionitrile compounds |
| 04/24/2001 | CA2073166C Process to correct and optimize the composition of a feed |
| 04/24/2001 | CA2070659C Antibody preparation |
| 04/24/2001 | CA2046397C Inflammatory bowel disease preventive and curative agents containing zinc l- carnosine salt or complex as active ingredient |
| 04/24/2001 | CA2002210C Expression and processing of authentic fgf's in yeast |
| 04/24/2001 | CA1341216C Human .alpha.-1-antitrypsin derivatives, and a production process |
| 04/19/2001 | WO2001027628A1 Antibiotic-metal complexes in the detection of gram-negative bacteria and other biological analytes |
| 04/19/2001 | WO2001027622A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 04/19/2001 | WO2001027334A2 Methods and compositions for correlating ccr5 expression with essential hypertension |
| 04/19/2001 | WO2001027290A2 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 04/19/2001 | WO2001027289A2 Recombinant proteins and peptides for endotoxin biosensors, endotoxin removal, and anti-microbial and anti-endotoxin therapeutics |
| 04/19/2001 | WO2001027286A1 Process for producing ubiquinone-10 |